These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2627617)

  • 1. Graft versus host disease in children: the AIEOP BMT group experience.
    Porta F; Nespoli L; Uderzo C; Conter V; Miniero R; Arcese W; Dini G; Colleselli P; Bagnulo S; Andolina M
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():149-50. PubMed ID: 2627617
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancement of BMT management in children and adults.
    Torlontano G; Di Girolamo G; Di Bartolomeo P; Angrilli F; Papalinetti G; Olioso P; Dragani A; Fioritoni G; Iacone A; D'Antonio D
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():59-60. PubMed ID: 2516756
    [No Abstract]   [Full Text] [Related]  

  • 3. Graft-versus-host disease in children: the AIEOP-BMT Group experience with cyclosporin A.
    Locatelli F; Uderzo C; Dini G; Zecca M; Arcese W; Messina C; Andolina M; Miniero R; Porta F; Rovelli A
    Bone Marrow Transplant; 1993 Dec; 12(6):627-33. PubMed ID: 8136746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMT in children: AIEOP experience. AIEOP BMT Group.
    Colleselli P; Paolucci P; Andolina M; Bagnulo S; Dini G; Meloni G; Miniero R; Porta F; Uderzo C; Rondelli R
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():58. PubMed ID: 2627625
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination of cyclosporine and methotrexate for prophylaxis of acute graft versus host disease after allogeneic bone marrow transplantation for leukaemias.
    Mrsić M; Labar B; Bogdanić V; Nemet D; Pavletić Z; Plavsić F; Dobrić I; Kastelan A; Marusić M; Zupancić-Salek S
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():95-6. PubMed ID: 2697416
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone marrow transplantation and graft-versus-host disease.
    Powles RL
    Curr Opin Immunol; 1989-1990; 2(6):870-5. PubMed ID: 2486567
    [No Abstract]   [Full Text] [Related]  

  • 7. Allogeneic bone marrow transplantation in children at Huddinge Hospital.
    Ringdén O; Bolme P; Lönnqvist B; Tollemar J; Borgström B; Dohlhöf G; Lundgren G; Winiarski J; Gahrton G; Groth CG
    Transplant Proc; 1988 Jun; 20(3):487-90. PubMed ID: 3289190
    [No Abstract]   [Full Text] [Related]  

  • 8. Results of four different protocols for prophylaxis against graft-versus-host disease.
    Tollemar J; Ringdén O; Bäckman L; Janossy G; Lönnqvist B; Markling L; Philstedt P; Sundberg B
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3008-10. PubMed ID: 2650414
    [No Abstract]   [Full Text] [Related]  

  • 9. Allogeneic bone marrow transplantation in children with ANL: Italian experience. AIEOP Group and the GITMO.
    Dini G; Abla O; Uderzo C; Polchi P; Locatelli F; Di Bartolomeo P; Arcese W; Messina C; Bandini G; Andolina M
    Bone Marrow Transplant; 1991; 7 Suppl 3():76-7. PubMed ID: 1855094
    [No Abstract]   [Full Text] [Related]  

  • 10. Graft-versus-host disease following bone marrow transplantation: clinical feature and diagnosis.
    Kikuta A; Suzuki H
    Fukushima J Med Sci; 1993 Dec; 39(2):95-9. PubMed ID: 7927140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia.
    Mehta J; Powles R; Singhal S; Iveson T; Treleaven J; Catovsky D
    Bone Marrow Transplant; 1996 Mar; 17(3):371-5. PubMed ID: 8704689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute graft-versus-host disease following bone marrow transplantation in humans: prognostic factors. Advisory Committee of the International Bone Marrow Transplant Registry.
    Bortin MM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2655-7. PubMed ID: 3274576
    [No Abstract]   [Full Text] [Related]  

  • 13. Graft versus host disease.
    Gordon-Smith EC
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):413-9. PubMed ID: 2480283
    [No Abstract]   [Full Text] [Related]  

  • 14. Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia.
    Rondón G; Giralt S; Huh Y; Khouri I; Andersson B; Andreeff M; Champlin R
    Bone Marrow Transplant; 1996 Sep; 18(3):669-72. PubMed ID: 8879640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early deaths in children after bone marrow transplantation: data of the AIEOP BMT Group.
    Garaventa A; Dini G; Bagnulo S; Bonetti F; Brutti F; Colleselli P; De Manzini A; Meloni G; Miniero R; Paolucci P
    Bone Marrow Transplant; 1991; 7 Suppl 2():55. PubMed ID: 1878720
    [No Abstract]   [Full Text] [Related]  

  • 16. Unrelated donor bone marrow transplantation for 100 pediatric patients: a single institute's experience.
    Yumura-Yagi K; Inoue M; Sakata N; Okamura T; Yasui M; Sawada A; Sato E; Chayama K; Endo C; Sasabe M; Miyamura T; Park YD; Nakano T; Inagaki J; Kishimoto T; Nomura K; Saito I; Hamada S; Nakano T; Hashii Y; Kawa K
    Bone Marrow Transplant; 2005 Aug; 36(4):307-13. PubMed ID: 15968285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graft-versus-host disease: effects on long term disease free survival in marrow transplantation for haematological malignancies.
    Kapoor N; Copelan EA; Klein J; Tutschka PJ
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():153-5. PubMed ID: 2697430
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous gammaglobulin therapy: current role in bone marrow transplant, malignancy, and immune hematologic disorders.
    Sacher RA
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):1-5. PubMed ID: 1509288
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
    J Clin Oncol; 2004 Feb; 22(3):416-23. PubMed ID: 14691124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic bone marrow transplantation in the treatment of hematologic diseases.
    Yee GC; McGuire TR
    Clin Pharm; 1985; 4(2):149-60. PubMed ID: 3886273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.